Source link : https://newshealth.biz/health-news/fda-opens-early-access-to-novel-pancreatic-cancer-drug-generating-buzz/
The FDA has given the green light to an expanded access program (EAP) for the investigational pancreatic cancer drug daraxonrasib. In a “safe to proceed” letter to Revolution Medicines, the FDA gave its approval to initiate the EAP in collaboration with licensed prescribers. The approval came just 2 days after the FDA received the company’s […]
The post FDA Opens Early Access to Novel Pancreatic Cancer Drug Generating Buzz first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-01 19:30:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8